Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P
Technology
Stats
- 25,345 US PATENTS IN FORCE
- 47,134 US APPLICATIONS PENDING
- 15,724 Total Patent Owners
- 218,291 TOTAL INVENTORS
Subclasses
| Subclass | Title |
|---|---|
| 1/00 | Drugs for disorders of the alimentary tract or the digestive system |
| 1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
| 1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
| 1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
| 1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
| 1/10 | Drugs for disorders of the alimentary tract or the digestive system Laxatives |
| 1/12 | Drugs for disorders of the alimentary tract or the digestive system Antidiarrhoeals |
| 1/14 | Drugs for disorders of the alimentary tract or the digestive system Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
| 1/16 | Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
| 1/18 | Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
| 3/00 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) |
| 3/02 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Nutrients, e.g. vitamins, minerals |
| 3/04 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents |
| 3/06 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics |
| 3/08 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) |
| 3/10 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) for hyperglycaemia, e.g. antidiabetics |
| 3/12 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis |
| 3/14 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04) |
| 5/00 | Drugs for disorders of the endocrine system |
| 5/02 | Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| RE49948 | Aryl ethers and uses thereof | Feb 03, 22 | Apr 30, 24 | Peloton Therapeutics, Inc. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0156,717 | COMPOSITION FOR ENHANCING SKIN WHITENING EFFECT ACCORDING TO AUTOPHAGY ACTIVITY WITH NYPA FRUTICANS EXTRACT AS AN ACTIVE INGREDIENT | Nov 07, 23 | May 16, 24 | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION |
| 2024/0156,719 | PHARMACOTHERAPY OF NEUROSYSTEM DYSFUNCTIONS | Mar 04, 22 | May 16, 24 | Not available |
| 2024/0156,720 | COMPOSITIONS FOR BLOOD STORAGE AND TRANSFUSIONS | Jan 23, 24 | May 16, 24 | Not available |
| 2024/0156,722 | DRUG DELIVERY FORMULATIONS | Dec 20, 23 | May 16, 24 | MedinCell S.A. |
| 2024/0156,730 | HYDROXYETHYCELLULOSE GEL COMPOSITION COMPRISING BACTERIOPHAGES | Jul 07, 23 | May 16, 24 | Not available |
| 2024/0156,751 | COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS | Jan 25, 24 | May 16, 24 | Not available |
| 2024/0156,752 | ENDOXIFEN FOR TREATMENT OF OVARIAN CANCER | Mar 10, 22 | May 16, 24 | Not available |
| 2024/0156,753 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | Jan 23, 24 | May 16, 24 | Not available |
| 2024/0156,755 | USE OF RIP1 INHIBITOR OR MLKL INHIBITOR FOR TREATING OR PREVENTING HEREDITARY RETINAL DYSTROPHY | Dec 20, 22 | May 16, 24 | Not available |
| 2024/0156,757 | CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF SEIZURES | Mar 03, 22 | May 16, 24 | Not available |
| 2024/0156,758 | METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING | Jan 19, 24 | May 16, 24 | Not available |
| 2024/0156,760 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | Jan 17, 24 | May 16, 24 | Not available |
| 2024/0156,761 | Magnesium Threonate Compositions and Uses Thereof | Jun 15, 23 | May 16, 24 | Not available |
| 2024/0156,763 | METHODS OF TREATMENT OF CHOLESTATIC DISEASES | Nov 09, 23 | May 16, 24 | Not available |
| 2024/0156,764 | INHIBITION OF URACIL DNA GLYCOSYLASE IN THE OPEN CONFORMATION | Mar 01, 23 | May 16, 24 | Not available |
| 2024/0156,765 | METHODS OF NEUROPROTECTION AND USES THEREOF | Jan 23, 24 | May 16, 24 | Not available |
| 2024/0156,767 | SCREENING METHOD FOR GLP-1 SECRETION REGULATION AGENT, GLP-1 SECRETION REGULATION AGENT, COMPOSITION FOR PREVENTING OR AMELIORATING DIABETES, OBESITY, POSTPRANDIAL HYPERGLYCEMIA, NEURODEGENERATIVE DISEASE, HYPOGLYCEMIA, ADIPOSITY, OR NESIDIOBLASTOSIS, METHOD FOR PROMOTING SECRETION OF GLP-1 IN GPR84-EXPRESSING CELLS, METHOD FOR PRODUCING COMPOSITION FOR PROMOTING SECRETION OF GLP-1, USE OF GPR84 AGONIST FOR PRODUCING THERAPEUTIC AGENT FOR DISEASE, GLP-1 SECRETION PROMOTION AGENT, AND... | Jan 25, 22 | May 16, 24 | Not available |
| 2024/0156,769 | FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | Jan 22, 24 | May 16, 24 | Not available |
| 2024/0156,771 | KETOGENIC COMPOSITIONS & METHODS OF USE THEREOF | Sep 26, 23 | May 16, 24 | Not available |
| 2024/0156,775 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | Jan 18, 24 | May 16, 24 | Not available |
Top Owners in This Class
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
Applications Filed in This Class - By Year
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)